No Photo Available

Last Update

2016-11-08T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Christos Petropoulos?

Dr. Christos J. Petropoulos

Vice President

LabCorp

HQ Phone: (336) 229-1127

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

LabCorp

358 S Main St

Burlington, North Carolina 27215

United States

Company Description

Laboratory Corporation of America Holdings, an S&P 500 company, is the world's leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covanc ... more

Find other employees at this company (11,293)

Background Information

Employment History

Chief Scientific Officer

Monogram Biosciences , Inc.

Molecular Virology Laboratory

Genentech , Inc.

Affiliations

Post-Doctoral Fellow
NCI-Frederick

Post Doctoral Fellow
National Cancer Institute

Founder
Replication Capacity

Education

PhD

molecular and cell biology

Brown University

Web References (181 Total References)


Executive Committee - Forum for Collaborative HIV Research

www.hivforum.org [cached]

Chris Petropoulos, PhD Chief Scientific Officer, Monogram Biosciences Vice President, LabCorp


Senior Scientific Team - LabCorp Clinical Trials

www.labcorpclinicaltrials.com [cached]

Christos Petropoulos, PhD Chief Scientific Officer, Monogram Biosciences, a LabCorp Company

Christos J. Petropoulos, PhD is VP of R&D and Chief Scientific Officer of Monogram Biosciences, a LabCorp specialty laboratory. He joined Monogram in 1996 from Genentech where he headed the Molecular Virology Laboratory.
Dr. Petropoulos received his PhD in molecular and cell biology from Brown University and trained as a post-doctoral fellow at the NCI Frederick Cancer Research and Development Center.
Dr. Petropoulos has co-authored over 145 scientific journal publications, is co-inventor on 12 issued US patents, and has been awarded 12 small business innovative research grants from the National Institutes of Health.


Monogram Biosciences Management

www.monogrambio.com [cached]

Christos J. Petropoulos, PhD

...
Christos J. Petropoulos, PhD is Vice President of Research and Development and Chief Scientific Officer of Monogram Biosciences, as well as Vice President at LabCorp Inc. Dr. Petropoulos joined Monogram as Director of Research and Development in August 1996, became Senior Director of Research and Development in September 1997, was named Vice President, Research and Development in November 1999 and was named Vice President, Research and Development, Virology and Chief Scientific Officer in December 2004. In September 2010, Dr. Petropoulos assumed direct responsibility for Monogram's Oncology R&D program in addition to the Virology R&D activities. From 1992 to 1996, Dr. Petropoulos was a scientist at Genentech where he headed the Molecular Virology Laboratory from 1992-1996 as well as the Research Virology and Molecular Detection Laboratories from 1994 to 1996. Dr. Petropoulos received his PhD in molecular and cell biology from Brown University and trained as a post-doctoral fellow at the National Cancer Institute's Frederick Cancer Research and Development Center. Dr Petropoulos has co-authored over 120 scientific publications, is co-inventor on 20 issued patents and has been awarded 12 research grants from the National Institutes of Health.


LabCorp launches HCV nucleic acid sequencing assay - Medical Devices Business Review

invitrodiagnostics.medicaldevices-business-review.com [cached]

LabCorp Monogram Research & Development vice president Chris Petropoulos said HCV GenoSure NS3/4A represents the first in a series of HCV drug resistance assays that have been developed at Monogram Biosciences to support the clinical evaluation of HCV direct-acting antiviral (DAA) agents and their use in the management of HCV infection.

"We look forward to expanding our broad HCV assay portfolio to support the development and clinical application of additional DAA agents that target other distinct steps in the HCV replication cycle," Petropoulos said.


"HCV GenoSure NS3/4A represents the first ...

www.fiercepharma.com [cached]

"HCV GenoSure NS3/4A represents the first in a series of HCV drug resistance assays that have been developed at Monogram Biosciences to support the clinical evaluation of HCV direct-acting antiviral (DAA) agents and their use in the management of HCV infection," commented Chris Petropoulos, PhD, LabCorp's Vice President of Monogram Research & Development.

Similar Profiles

Other People with this Name

Other people with the name Petropoulos

Elena Petropoulos
Petite Portions

John Petropoulos
Mercury Group of Companies

Stefanie Petropoulos
Public Relations

Ian Petropoulos
KPMG LLP

Demetrios Petropoulos
MD Anderson Cancer Center

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory